Purchase Order 75N95021P00041
Award Date 12/16/20
Potential Completion Date 10/31/23
Potential Value $100K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The potential value of the contract is $120,201.95 and the period of performance runs through August 29, 2023. The original solicitation indicated that the government intended to award this sole source contract to Illumina for support plans covering their MiSeq, NovaSeq 6000,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a MiSeq Silver Support Plan. The contract is valued at $15,575.00 and has a completion date of March 25, 2025. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has previously provided sequencing systems and consumables to support research and diagnostics...
- This is a $16,198 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq Silver Support Plan with an ultimate completion date of February 5, 2026. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has been awarded previous prime contracts and subcontracts by federal...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed-price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $30,852.00 contract is for a MiSeq Gold Support Plan service agreement, with a completion date of December 12, 2024. Illumina has previously been awarded prime federal contracts by agencies such as the NIH, CDC, USDA, and VA to provide a range...
- The National Institutes of Health Clinical Center awarded a $60,442 firm fixed price purchase order to Illumina, Inc. for one-year maintenance support of two NextSeq 1000 sequencers under its Silver Support Plan. The contract, awarded on November 13, 2025, with an ultimate completion date of November 12, 2026, was procured as a sole-source acquisition under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures. The contracting officer determined that Illumina is the only...
- Illumina, Inc. was awarded a $48,209 firm fixed price purchase order for a NEXTSEQ 2000 SILVER SUPPORT PLAN by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The support plan is for a NEXTSEQ 2000 sequencing system located at the agency's facilities in Bethesda, Maryland and provides maintenance services for the proprietary instrumentation through March 2025. No set-aside provision was applied to this acquisition of sequencing system support from the...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $21,171 firm fixed price purchase order to Illumina, Inc. for the annual renewal of the NextSeq bronze support plan. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver maintenance services for the NextSeq sequencing system located in Rockville, Maryland under this contract. No set-aside provision was utilized for this...
- This is a firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq support plan. The contract has a ceiling value of $85,029.08 and a period of performance through September 11, 2029. Illumina, a manufacturer of genetic sequencing instruments and reagents, has provided a range of sequencing products and services to support research and diagnostics across various...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $266,475.00 order was for a NextSeq 550 Sequencing System, shipping, maintenance, software licenses, and technical support to support the NIH Clinical Center's Department of Transfusion Medicine and its blood collection and research activities. The contract was...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Illumina, Inc. for a SILVER SUPPORT PLAN ON NOVASEQ6000 S/N A00428 with a potential value of $22,646.33 and a completion date of February 4, 2024. This short-term contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic sequencing and analysis instruments and reagents, has a history of providing...